Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45Endometrial Neoplasms 10Triple Negative Breast Neoplasms 4Ovarian Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Progesterone Resistance 2HR+/HER2- Breast Cancer 2HR Positive HER2 Negative Advanced Breast Cancer 2Endometrial Hyperplasia 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peritoneal Neoplasms 1Pathologic Complete Response 1Obesity 1Neoplasms by Site 1Low-Grade Serous Ovarian Cancer 1Low Grade Serous Ovarian Carcinoma 1Low Grade Serous Ovarian Cancer 1Locoregional Recurrence 1Leiomyoma 1Infertility, Female 1Infertility 1

Interventions

Thyroxine 1Tablets 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Infertility, Female × Letrozole × Clear all
NCT06041204 2025-09-03

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Al-Azhar University

Phase NA Recruiting
200 enrolled

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡